反応 #2186208
ord-7e3aa44568994649a2ef2db65678e6ec
反応方程式
sodium bicarbonate
3-Benzothiazol-2-yl-7-[4-(3-hydroxy-propyl)-piperazin-1-yl]-chromen-2-one
Hünig base
tosyl chloride
→
Toluene-4-sulfonic acid 3-[4-(3-benzothiazol-2-yl-2-oxo-2H-chromen-7-yl)-piperazin-1-yl]-propyl ester
反応物
試薬
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1workup.ADDITIONpoured onto ice
- 2抽出extracted (dichloromethane, saline)
- 3その他The organic phase is evaporated
- 4その他the residue column chromatographed (silica gel, dichloromethane/EtOH 98:2)
- 5その他to yield
- 6その他after evaporation
- 7乾燥drying under high vacuum 73 mg (78%) desired product as a light brownish powder
実験手順
70 mg (0.16 mmol) 3-Benzothiazol-2-yl-7-[4-(3-hydroxy-propyl)-piperazin-1-yl]-chromen-2-one are dissolved in 15 mL dichloromethane under argon. 0.083 mL Hünig base and 10 mg DMAP are added to the stirred solution, followed by 46 mg (1.5 eq.) tosyl chloride. The reaction mixture is stirred for 20 h at room temperature, poured onto ice, treated with 2 mL aqueous sodium bicarbonate solution and extracted (dichloromethane, saline). The organic phase is evaporated and the residue column chromatographed (silica gel, dichloromethane/EtOH 98:2) to yield after evaporation and drying under high vacuum 73 mg (78%) desired product as a light brownish powder.